Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-5403
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease ; day:16 ; month:12 ; year:2020 ; pages:1-13
Cell death and differentiation ; (16.12.2020), 1-13

Urheber
Milanese, Chiara
Gabriels, Sylvia
Barnhoorn, Sander
Cerri, Silvia
Ulusoy, Ayşe
Gornati, S. V.
Wallace, Daniel F.
Blandini, Fabio
Di Monte, Donato A.
Subramaniam, V. Nathan
Mastroberardino, Pier G.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41418-020-00698-4
URN
urn:nbn:de:101:1-2021012306110634660753
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:21 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Milanese, Chiara
  • Gabriels, Sylvia
  • Barnhoorn, Sander
  • Cerri, Silvia
  • Ulusoy, Ayşe
  • Gornati, S. V.
  • Wallace, Daniel F.
  • Blandini, Fabio
  • Di Monte, Donato A.
  • Subramaniam, V. Nathan
  • Mastroberardino, Pier G.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model

Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model

Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation

Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation

Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?

Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?

Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease

Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease

Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease

Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease

TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition

TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition

Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment

Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment

Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease

Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease

CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival

CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival

Verbundene Objekte